Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Cannabinol

Is Cannabinol legal in Germany?

Confirmed against a primary sourceVerified September 21, 2026
Legal status
Cannabinol is not a scheduled substance in Germany on this reading, and the row turns on a rejection that is easy to get wrong. The search ran on 20 September 2026 across BtMG Anlagen I bis III and NpSG Anlagen 1 und 2 under „Cannabinol; CBN“ and returned no entry. The near entry the dossier considered and rejected is the narcotics line that opens „Tetrahydrocannabinole, folgende Isomeren...“, which names the tetrahydro isomers and not the fully aromatic cannabinol: a shared plant origin and a shared abbreviation family are not a listing. The dossier is equally careful about the second route, recording that the new psychoactive substances group at Nr. 2 catches only the printed core structures and substituents, so a structural claim would have to be demonstrated rather than assumed from the name.
Consequences if caught
Capital exposure: none. Germany has no death penalty. No narcotics maximum applies either, because the dossier's finding is a confirmed absence and a penalty cannot be attached to an entry that does not exist. The care needed on this row is about the second statute rather than the first: nothing has been shown to place this molecule in a new psychoactive substances group, so neither the prohibition in that Act nor its offence provision is engaged, and a penalty from that regime must not be carried across on the strength of the neighbouring cannabinoid groups. What is left is product law, which turns on the article sold rather than on the molecule.
If prescribed or medical
No narcotics placement exists to carry a traveller rule. The relevant separate regimes the dossier names are the cannabis statute's own definition and the medicines regime, and both operate on a product rather than on an isolated cannabinoid. The dossier records no German prescription rule and no traveller rule for this row, so the cell defers on both instead of supplying one.
Documentation
For a product containing this cannabinoid the useful record is its composition and its presentation, since the only live questions are whether the material is within the cannabis definition and how the finished product is classified. No narcotics certificate arises. The search was run on 20 September 2026 and the absence is an absence as at that text.
Primary sources
  • Germany, confirmed absence from Betäubungsmittelgesetz Anlagen I bis III and Neue-psychoaktive-Stoffe-Gesetz Anlagen 1 und 2 on the terms „Cannabinol
  • CBN“, with the tetrahydrocannabinol isomer line considered and rejected as naming different molecules
  • read at https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html and the companion Anlage pages on 20 September 2026
  • the cannabis definition consulted is KCanG § 1 at https://www.gesetze-im-internet.de/kcang/__1.html

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

Other substances confirmed in Germany